For instance, one previous study elucidates that CFI−400945 (a PLK4 inhibitor) suppresses the proliferation and facilitates the apoptosis of rhabdoid tumor cell lines.14 Another illustrates that CFI−400945 suppresses breast cancer cell proliferation in vitro and inhibits tumor growth in vivo. Here, PLK4 is linked to breast carcinoma.